Skip to main content
. 2020 Jun 19;10:9948. doi: 10.1038/s41598-020-67031-4

Figure 1.

Figure 1

We enrolled 193 patients presented with cryptococcal meningitis from December 2001 to December 2013, 100 patients met the requirements according to inclusion criteria and were divided into two groups (CM-IRIS group and CM non-IRIS group) depends on whether IRIS developed or not and conducted comparative analysis of curative effectiveness. Furthermore we divided CM-IRIS group into two groups: CM-IRIS treated with GCs and CM-IRIS treated without GCs, and did comparative analysis of not only curative effectiveness but also incidence of IRIS.